Drug intelligence / Profile preview

Alcof Expectorant

Development stage
Unknown
Lead developer
Dawa Life Sciences
Modality
Small Molecules
Administration
Oral
01

Overview

Alcof Expectorant is an approved combination cough syrup developed and manufactured by Dawa Life Sciences. It is formulated with three active ingredients: ammonium chloride, chlorpheniramine maleate, and sodium citrate. Ammonium chloride acts as an expectorant by irritating the gastric mucosa, which reflexively stimulates the secretion of respiratory tract fluid to thin and loosen phlegm. Chlorpheniramine maleate is a first-generation antihistamine that competitively blocks histamine H1 receptors, thereby relieving allergic symptoms such as runny nose, sneezing, and watery eyes. Sodium citrate serves as a mucolytic agent that alters mucus pH to reduce its viscosity, facilitating easier clearance of the airways. Alcof Expectorant is indicated for the symptomatic relief of productive coughs associated with the common cold, bronchitis, and upper respiratory tract allergies.

Brand names
Alcof Expectorant
Other names
AlcofAlcof Cough Expectorant
02

Targets

mAChR (Muscarinic acetylcholine receptors)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Alcof Expectorant.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alcof Expectorant.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call